Privatlivspræferencer
Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.
  • Forum
  • Premium
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • PorteføljeInderes modelportefølje
  • Lær om investering
    • AnalyseskoleLær at læse og forstå aktieanalyse
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • InsidertransaktionerFølg købs- og salgsaktivitet fra virksomhedsinsidere
    • ShortsalgSe hvilke børsnoterede selskaber der har offentliggjorte korte positioner
    • Virtuel analytiker-chatStil spørgsmål og få AI-drevne investeringsindsigter med det samme
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Qualisys Releases Prisma Pose - Markerless Motion Capture for Biomechanics Labs

QSYSPressemeddelelse02.11.2026, 14.00

Qualisys today released Prisma Pose, the company’s own markerless engine, in Qualisys Track Manager (QTM), the motion capture software its customers have relied on for more than 20 years. Prisma Pose is sold as an add-on license for customers using Qualisys video camera systems. It is now available for purchase from Qualisys and its distributors.

Developed in-house, Prisma Pose lets labs capture human movement without placing markers on participants. It gives biomechanics laboratories a practical and accessible solution, with no need for an additional software vendor.

Demand for markerless capture is growing as labs look to assess populations where markers are impractical, with less setup and a simpler workflow. Live demonstrations at international conferences and regional events, and a webinar prior to launch, drew strong interest. The response also points to opportunities beyond research labs, including physiotherapy and private practice.

Added Value for an Established Customer Base
As a one-time add-on license for labs running QTM worldwide, Prisma Pose adds markereless capabilities to existing systems. It works only with Qualisys video cameras, which also supports camera system sales. Updates come through the Qualisys Support and Update Agreement, giving customers one more reason to renew.

“Markerless is one of the directions our market is moving in, and one of several growth areas for Qualisys. With Prisma Pose, biomechanics labs can go markerless inside the system they already use, which will simplify their workday and open up new research opportunities," says Ingemar Pettersson, CEO of Qualisys.

A Complete Markerless Portfolio
Different customers, different business models. Prisma Pose is a one-time add-on license to QTM, while OnTraq, already available to elite sport teams, is subscription-based. The long-standing Theia partnership serves laboratories with more extensive requirements. Together they give Qualisys a differentiated product portfolio across the full markerless spectrum – one of the fastest-growing segments in human movement research.

Read more at www.qualisys.com/features/markerless-motion-capture

For more information, please contact:
Ingemar Pettersson, CEO
E-mail: Ingemar.Pettersson@qualisys.se

About Qualisys Holding AB (publ)
Qualisys is a leading provider of motion capture technology and has a long history of supplying research, engineering, entertainment, and sports facilities with high-end camera systems and expertise in capturing and analyzing movements. Qualisys offers a wide range of products and services with its headquarter in Gothenburg, Sweden, and operations in Chicago, Singapore, Shanghai and Delhi. Qualisys is certified according to ISO 9001:2015 and ISO 27001:2023. The clinical products are compliant with Medical Device Directive 93/42/EEC and have FDA clearance (K171547).

Qualisys is listed on Nasdaq First North Premier Growth Market. The company’s Certified Adviser is Svensk Kapitalmarknadsgranskning AB.

Attachments
Qualisys Releases Prisma Pose - Markerless Motion Capture for Biomechanics Labs